1st Quarter Results
INTERIM MANAGEMENT STATEMENT Q1 2012
1 May 2012
Q1 ON TRACK
2012 FULL YEAR TARGETS REITERATED
Results at a glance Q1 % change % change
£m actual exchange constant exchange
Net Revenue 2,357 +3% +4%
- Like-for-like growth (ex +4%
RBP) *
Net Revenue by Segment
-ENA 1,168 -2% -1%
-LAPAC 580 +13% +13%
-RUMEA 369 +5% +9%
-Food 73 +7% +6%
Total ex RBP 2,190 +3% +4%
-RB Pharmaceuticals 167 +7% +6%
Total Net Revenue 2,357 +3% +4%
Net Revenue by Category
-Health 461 +0% +0%
-Hygiene 964 +5% +7%
-Home 486 +1% +2%
-Portfolio Brands 206 +0% +2%
* Like-for-like ("LFL") growth excludes the impact of changes in exchange
rates, acquisitions, disposals and discontinued operations.
Highlights: Q1
* Like-for-like net revenue growth excluding RBP of 4%, well ahead of our
market growth
* Strong growth in emerging market areas
* Satisfactory performance in ENA in challenging market conditions
* Growth driven by Dettol / Lysol, Harpic, Finish, and Durex
* RBP - volume (mg) market share of Film grown to 53%
Commenting on these results, Rakesh Kapoor, Chief Executive Officer, said:
"Reckitt Benckiser's first quarter results were on track and in line with our
ingoing expectations. High quality, volume led LFL growth of 4% was driven by c
ontinued excellent performance in Emerging Market Areas and the success of
innovations like Veet Easy Wax Roll-On and the Lysol No-Touch Kitchen System.
RBP continues to make very good progress with the patient preferred Suboxone
sublingual film now at 53% market volume share, up from 48% at the end of 2011.
These results give us the confidence to reiterate our FY 2012 target of
like-for-like net revenue growth* of 200bp above our market growth rate of
1-2%. We also expect to maintain full year operating margins.*"
*ex RBP
Summary Analysis: % net revenue growth
Q1 2012 Like-for-like Acquisitions & Exchange Reported
Disposals*
ENA -1% +0% -1% -2%
LAPAC +11% +2% +0% +13%
RUMEA +9% +0% -4% +5%
Food +6% +0% +1% +7%
TOTAL ex RBP +4% +0% -1% +3%
RBP +6% +0% +1% +7%
TOTAL GROUP +4% +0% -1% +3%
* Reflects the acquisition of Paras, disposals, and discontinuance of Propack
(Private Label) and a number of minor businesses.
ENA 55% of core net revenue
Q1 2012 net revenue declined to £1,168m, with LFL growth of -1%. Good growth in
Hygiene was offset by a poor `flu season which impacted Health. The strong
performance in Hygiene came behind Dettol, Lysol, Finish and Veet, which
benefited from such recent initiatives as the Lysol No-Touch Kitchen System and
Veet Easy Wax Electrical Roll-On. In the US, Finish Quantum and All-in-1
tablets and gel packs continued to perform well. Trends in Home continue to
improve with more stable performances in Vanish, although Laundry Detergents
and Fabric softeners in Southern Europe remain weak.
LAPAC 27% of core net revenue
Q1 2012 net revenue increased to £580m with growth of +13% constant (+11% LFL).
There was good growth across all regions, driven by a combination of Powerbrand
rollouts, innovation and share gains. In Health, Nurofen, Scholl and Durex
performed well, and Vanish and Airwick drove the growth in Home. The strong
performance in Hygiene was driven by Finish, Harpic and Dettol, behind recent
initiatives like Dettol Daily Care and Re-energize, plus High Performance for
Men soap and shower gels.
RUMEA 18% of core net revenue
Q1 2012 net revenue increased to £369m, with LFL growth of +9% with good growth
across all regions. On a category basis, Health was driven by strong
performances in Durex and Gaviscon. Hygiene performed particularly well behind
Finish and Dettol, driven by initiatives such as Dettol Daily Care and
Re-energize. Air Wick also performed well in the Home category, driven by
continued growth in Freshmatic and Aqua Mist.
Food
Food experienced a continued strong performance with constant and LFL growth of
+6%.
Pharmaceuticals
Q1 2012 net revenue increased +6% (constant) to £167m. We continue to see
strong conversion from tablets to film as we focus on driving a more
sustainable business in the US. Good market growth in the US was not fully
reflected in the net revenue growth due to dilution from continued strong film
penetration and Medicaid rebates which are now being accrued at the new higher
levels.
Q1 2012 Category Review (at Constant Exchange Rates)
Health. Net revenue increased +0% (+1% LFL) to £461m. A poor `flu season
impacted Mucinex, Strepsils and select products within Nurofen. Other brands,
not susceptible to the `flu season, performed well, with strong performances
from Durex and Gaviscon, supported by new initiatives such as Performax Intense
condoms.
Hygiene. Net revenue increased +7% (+6% LFL) to £964m, largely driven by strong
growth in Dettol / Lysol across Emerging Markets as well as ENA, supported by
new initiatives such as the Lysol No-Touch Kitchen System in the US, and Dettol
Daily Care and Re-energize in Emerging Markets. Finish Quantum and All-in-1
continue to perform well, particularly in the US where it gained further market
share. Early success of Veet Easy Wax Electrical Roll-On is driving good
growth, whilst Harpic continues to deliver sustained growth momentum.
Home. Net revenue increased +2% (+2% LFL) to £486m. Growth came from Vanish
where shares continue to stabilise as we are lapping competitive entries in
Europe, combined with very strong growth in certain emerging market countries.
Air Wick also produced a solid performance behind Freshmatic, candles and the
recently introduced Flip & Fresh.
Portfolio Brands. Reported net revenue increased +2% to £206m, largely due to
the inclusion of Paras personal care products which were acquired in April
2011. On a LFL basis net revenue declined slightly (-1%) as a more stable
performance was offset by continued weakness in Laundry Detergents and Fabric
Softeners in Southern Europe.
Financial Position
There has been no material change to the financial position of the company
since the published 2011 Annual Report and Accounts.
2012 Targets
The Q1 2012 results position the Group well to achieve its FY 2012 financial
targets.
For the Group excluding RBP, the target is for like-for-like net revenue growth
of +200 basis points ahead of our market growth. We continue to expect the
market to grow at 1-2%. We also expect to maintain margins (ex RBP) as we
invest behind brand equity building initiatives.
For further information, please contact:
Reckitt Benckiser +44 (0)1753 217800
Richard Joyce
Director, Investor Relations
Andraea Dawson-Shepherd
SVP, Global Corporate Communication & Affairs
Brunswick (Financial PR) +44 (0)20 7404 5959
David Litterick
Cautionary note concerning forward-looking statements
This document contains statements with respect to the financial condition,
results of operations and business of Reckitt Benckiser and certain of the
plans and objectives of the Group with respect to these items. These
forward-looking statements are made pursuant to the "Safe Harbor" provisions of
the United States Private Securities Litigation Reform Act of 1995. In
particular, all statements that express forecasts, expectations and projections
with respect to future matters, including trends in results of operations,
margins, growth rates, overall market trends, the impact of interest or
exchange rates, the availability of financing to the Company, anticipated cost
savings or synergies and the completion of strategic transactions are
forward-looking statements. By their nature, forward-looking statements involve
risk and uncertainty because they relate to events and depend on circumstances
that will occur in the future. There are a number of factors discussed in this
report, that could cause actual results and developments to differ materially
from those expressed or implied by these forward-looking statements, including
many factors outside Reckitt Benckiser's control. Past performance cannot be
relied upon as a guide to future performance.
Basis of Presentation and Exceptional Items
Where appropriate, the term "like-for-like" (LFL) describes the performance of
the business on a comparable basis, excluding the impact of acquisitions,
disposals, discontinued operations and foreign exchange.
Where appropriate, the term "core business" represents the ENA (Europe and
North America), RUMEA (Russia / CIS, Africa, North Africa, Middle East and
Turkey) and LAPAC (Latin America, North Asia, South Asia and ANZ) geographic
areas, and excludes RBP and RB Food.